The comparative pharmacology of angiotensin II receptor antagonists

Blood Pressure, Supplement

Volumn 10, Issue 1, 2001, Pages 6-11

  Burnier, M ^a   Maillard, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiotensin II receptor antagonists; Angiotensin II receptors; Pharmacodynamics; Pharmacokinetics; Receptor binding

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; IRBESARTAN; LOSARTAN; TELMISARTAN;

CONFERENCE PAPER; DISSOCIATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HEART PROTECTION; HYPERTENSION; PHARMACODYNAMICS; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0035070563     PISSN: 08038023     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370501750066444     Document Type: Conference Paper

References (28)

1. Angiotensin-II receptors: New targets for antihypertensive therapy
2. Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitors
3. Adverse effects of the angiotensin-converting enzyme inhibitors
4. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema
5. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
6. Short and long term effects of antihypertensive therapy in the diabetic rat
7. Angiotensin II receptor blockade in TGR(mREN2)27: Effects of renin-angiotensin-system gene expression and cardiovascular functions
8. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade
9. Non-insulin-dependent diabetes mellitus, nephropathy, and the renin system
10. 1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain
11. Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174
12. Candesartan cilexetil: A new, long-acting, effective angiotensin II type 1 receptor blocker
13. Chemistry of telmisartan, a highly lipophilic angiotensin II antagonist with a long duration of action
14. The distribution of angiotensin II type I receptors, and the tissue renin-angiotensin systems
15. Pharmacological mechanism of angiotensin II receptor antagonists: Implications for the treatment of elevated systolic blood pressure
16. Physiologic and pharmacologic implications of AT1 versus AT2 receptors
17. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277
18. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart
19. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart
20. Pharmacological properties of angiotensin II receptor antagonists
21. Candesartan (CV11974) dissociates slowly from the angiotensin AT1 receptor
22. Eprosartan
23. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists
24. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension
25. Comparative antihypertensive effects of angiotensin II receptor antagonists
26. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension
27. 1 receptor antagonists
28. Comparative safety and tolerability of angiotensin II receptor antagonists